Sean Nolan - Director, Taysha Gene Therapies, Inc
As of June 22, 2022
What is Sean Nolan's Net Worth?
The current estimated net worth of Taysha Gene Therapies, Inc's Director, Sean Nolan, is estimated to be about $6.57M . Sean Nolan owns about 1,092,271 units of Taysha Gene Therapies, Inc common stock. In the last 2 years at Taysha Gene Therapies, Inc, Sean Nolan has sold an estimated value of $0 worth.
What is Sean Nolan's Past Insider Trading?
Sean Nolan's largest purchase order was 1,170 units , worth over $26.15K on May 24, 2021. In total, Sean Nolan has made about 5 transactions over 2 years of their time at Taysha Gene Therapies, Inc. Sean Nolan usually trades in June and September, with the busiest year in 2020 and 2021.
Sean Nolan
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Sean Nolan's' Mailing Address?
- Mailing address is C/o Intermune, Inc. 3280 Bayshore Blvd. Brisbane CA 94005 CA
What are Taysha Gene Therapies, Inc's Past Insider Trades?
Taysha Gene Therapies, Inc's most recent insider trade came on February 4, 2022 by Paul Manning who bought 201,602 units worth $1.57M . In the last year, insiders at Taysha Gene Therapies, Inc have sold an estimated value of $2.34M and bought an estimated value of $2.76M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Paul Manning, Director, Suyash Prasad, CMO and Head R&D, and Kamran Alam, Chief Financial Officer .
Taysha Gene Therapies, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||